Testing microRNA levels to personalize heart transplant care
Part of Heart & circulation clinical trials.
This trial is studying whether a blood test that measures small molecules called microRNAs can help doctors personalize the medicines used to prevent rejection after a heart transplant. If you qualify, you would help researchers learn how to better match immunosuppression to each patient's needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a heart transplant within the past month (give or take two weeks).
- You are planning to continue follow-up care at the transplant center for at least a year.
- You are at least 18 years old.
- You are willing and able to follow the study's visit schedule and procedures.
- You have not had any other organ transplant before or at the same time as this heart transplant.
- You do not currently need a heart pump, kidney dialysis, or treatment for a serious infection or rejection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at heart transplant children (up to age 18) to see if measuring tiny molecules called microRNAs in the blood can help doctors personalize anti-rejection medicines. It aims to improve how we prevent rejection while reducing side effects.
This study tests whether a small biopsy taken from a donor heart before transplant can predict how well the heart will work after surgery. The goal is to improve transplant success for recipients.
This study checks how special lab tests on heart tissue samples can help guide diagnosis and treatment for people with a heart transplant. You may be eligible if you already need a heart tissue biopsy for a clinical reason and can provide consent.
This trial tests a special machine that preserves donor hearts for longer periods before transplant. It may help people waiting for a heart transplant who need a heart from a donor that may be older or has some heart risks.
This trial uses precise, personalized approaches to manage heart transplant recipients. It involves taking a small heart muscle sample (a biopsy) to monitor for rejection or routine checks.
This trial checks whether using heart-monitoring blood tests and biopsy results can help customize (optimize) immune-suppression medication soon after your transplant. It aims to keep the transplanted heart safe while avoiding over- or under-treatment.
Hear when a new Cardiac Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.